Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRNX Crinetics Pharmaceuticals Inc.

休市中 06-28 16:00:00 EDT

44.79

+1.32

+3.04%

盘后44.79

+0.000.00%

19:33 EDT

最高44.98	最低43.11	成交量478.11万
今开43.67	昨收43.47	日振幅4.30%
总市值35.32亿	流通市值30.66亿	总股本7,886万
成交额2.13亿	换手率6.98%	流通股本6,846万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRNX","market":"US","secType":"STK","nameCN":"Crinetics Pharmaceuticals Inc.","latestPrice":44.79,"timestamp":1719604800000,"preClose":43.47,"halted":0,"volume":4781074,"hourTrading":{"tag":"盘后","latestPrice":44.79,"preClose":44.79,"latestTime":"19:33 EDT","volume":1947737,"amount":87238876.125276,"timestamp":1719617585036},"delay":0,"floatShares":68460243,"shares":78859510,"eps":-3.76496,"marketStatus":"休市中","marketStatusCode":7,"change":1.32,"latestTime":"06-28 16:00:00 EDT","open":43.67,"high":44.98,"low":43.11,"amount":213335800.94123,"amplitude":0.043018,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.76496,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719820800000},"adr":0,"listingDate":1531886400000,"adjPreClose":43.47,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":43.47,"preClose":43.47,"latestTime":"08:00 EDT","volume":1,"amount":43.47,"timestamp":1719576000406},"postHourTrading":{"tag":"盘后","latestPrice":44.79,"preClose":44.79,"latestTime":"19:33 EDT","volume":1947737,"amount":87238876.125276,"timestamp":1719617585036},"volumeRatio":3.8670765384962014,"impliedVol":0.4377,"impliedVolPercentile":0.0079},"requestUrl":"/m/hq/s/CRNX","defaultTab":"news","newsList":[{"id":"2446139455","title":"Crinetics Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446139455","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446139455?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:29","pubTimestamp":1719412193,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时29分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.01%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626222953aef6c055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626222953aef6c055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2443466567","title":"Crinetics Pharmaceuticals, Inc.盘中异动 下午盘快速拉升5.11%报47.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443466567","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443466567?lang=zh_cn&edition=full","pubTime":"2024-06-13 01:03","pubTimestamp":1718211806,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日01时03分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.11%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061301032696813c71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061301032696813c71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","BK4139","CRNX"],"gpt_icon":0},{"id":"2440392112","title":"Crinetics Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440392112","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440392112?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:16","pubTimestamp":1717510598,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时16分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.08%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Annexon, Inc.、Cingulate Inc C/Wts 10/12/2026 、天境生物涨幅较大，Bio-Path Holdings, Inc.、Fresh2 Group Limited、Annexon, Inc.较为活跃，换手率分别为57.39%、38.38%、32.37%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.，振幅分别为181.00%、31.22%、28.08%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604221639941ec46d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604221639941ec46d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX","ANNX","BK4139"],"gpt_icon":0},{"id":"2440849457","title":"Crinetics Pharmaceuticals, Inc.盘中异动 快速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440849457","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440849457?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:58","pubTimestamp":1717426726,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日22时58分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.09%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603225847941ebefd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603225847941ebefd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2437910765","title":"Crinetics Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437910765","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437910765?lang=zh_cn&edition=full","pubTime":"2024-05-23 22:30","pubTimestamp":1716474621,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日22时30分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.03%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。消息层面，截至22时30分，《摩根士丹利维持Crinetics买入评级，上调目标价至70美元》资讯为影响Crinetics Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523223021af89ef59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523223021af89ef59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2437063207","title":"美国研究综述-模拟器件、Nvidia™（NVIDIA®）、Snowflake","url":"https://stock-news.laohu8.com/highlight/detail?id=2437063207","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437063207?lang=zh_cn&edition=full","pubTime":"2024-05-23 15:04","pubTimestamp":1716447896,"startTime":"0","endTime":"0","summary":"    路透5月23日 - 华尔街证券分析师周四调整了对模拟器件、Nvidia和雪花等几家美国上市公司的评级和目标价。要点  * 模拟器件公司  ：杰富瑞将目标价从250美元上调至280美元 * Dycom Industries Inc   ：D.A.戴维森将目标价从160美元上调至200美元 * Nvidia公司  ：Evercore ISI 将目标价从 1160 美元上调至 1310 美元 * Snowflake Inc   ：加拿大皇家银行将目标价从220美元上调至226美元 * Williams-Sonoma Inc   ：Jefferies将目标价从280美元上调至293美元 以下是路透周四报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRC","HAS","LU0234570918.USD","LU1951200564.SGD","BK4581","FSLR","LU0052756011.USD","NEP","SKY","COP","LU0053671581.USD","NSC","SYY","LU1974910355.USD","CRNX","ELF","MSDL","TJX","HASI","LU0072462426.USD","LU0128525689.USD","BNTX","GEV","LU2133065610.SGD","SNOW","WISA","WSM","BSGM","EXP","ZUO","MKSI","CRGY","DY","GDRX","TGT","TKR","NVDA","CYTK","TER","GNRC","LU0719512351.SGD","OKTA","LU0238689110.USD","DYN","SPIR","BK4592","TOL","AHCO","HEI","ADI"],"gpt_icon":0},{"id":"2437293720","title":"Crinetics Pharmaceuticals, Inc.盘中异动 大幅拉升5.62%报52.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437293720","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437293720?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:31","pubTimestamp":1716384697,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时31分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.62%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Mustang Bio, Inc.、Rezolute, Inc.涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为183.69%、88.76%、32.34%，振幅较大的相关个股有Nutriband Inc C/Wts 、Sol-Gel Technologies Ltd.、Eupraxia Pharmaceuticals Inc.，振幅分别为12.90%、10.55%、9.38%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052221313787879c3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052221313787879c3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2434864594","title":"摩根大通证券公司：重申Crinetics Pharmaceuticals(CRNX.US)评级，由优于大市调整至优于大市评级, 目标价80.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434864594","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434864594?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:55","pubTimestamp":1715360137,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：重申Crinetics Pharmaceuticals(CRNX.US)评级，由优于大市调整至优于大市评级, 目标价80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110055438af1bcbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110055438af1bcbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX"],"gpt_icon":0},{"id":"2434855383","title":"美国研究综述-Cerence、Epam Systems、Progyny","url":"https://stock-news.laohu8.com/highlight/detail?id=2434855383","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434855383?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:39","pubTimestamp":1715344798,"startTime":"0","endTime":"0","summary":"    路透5月10日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Cerence、Epam Systems 和 Progyny。要闻  * Cerence Inc   ：富国银行将其评级从 \"增持 \"下调至 \"等权重\"。* Epam Systems Inc   ：丰业银行将其评级从 \"跑赢大市 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","CE","OXY","BRT","AVAH","BK4548","FWRD","GAIN","ACAD","BK4539","CPAY","BK4109","OBDC","MKSI","MTRN","EPAM","FDMT","IFF","LU2463526074.USD","LU0053671581.USD","HBI","LYFT","FLNC","NTRA","CRL","CMI","LU0320765992.SGD","MRC","GO","EYE","CRNX","APLT","MGNX","ARWR","BK4227","PGNY","ARHS","FOLD","ANIK","NTLA","GFF","IE00B66KJ199.SGD","LU1815336091.USD","BK4533","GRWG","BIGC","MRCY","HLIO","YOU","LU0823414478.USD"],"gpt_icon":0},{"id":"2433729423","title":"Crinetics Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433729423","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433729423?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:30","pubTimestamp":1715175036,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时30分，Crinetics Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.03%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。该信息摘要如下：Piper Sandler：维持Crinetics Pharmaceuticals评级，由增持调整至增持评级, 目标价由56.00美元调整至97.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821303687e866ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821303687e866ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX","BK4139"],"gpt_icon":0},{"id":"2433277176","title":"Piper Sandler：维持Crinetics Pharmaceuticals(CRNX.US)评级，由增持调整至增持评级, 目标价由56.00美元调整至97.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433277176","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433277176?lang=zh_cn&edition=full","pubTime":"2024-05-07 19:25","pubTimestamp":1715081123,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Crinetics Pharmaceuticals(CRNX.US)评级，由增持调整至增持评级, 目标价由56.00美元调整至97.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405071925298ae4d097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405071925298ae4d097&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX"],"gpt_icon":0},{"id":"2433724078","title":"美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2433724078","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433724078?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:20","pubTimestamp":1715070052,"startTime":"0","endTime":"0","summary":"    路透5月7日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 ServiceNow、Ulta Beauty 和 Vertex Pharmaceuticals。要闻  * 艾睿电子  ：雷蒙德-詹姆斯将目标价从130美元上调至135美元 * Cardinal Health Inc   ：杰富瑞将目标价从110美元下调至105美元 * ServiceNow Inc   ：贝雅将目标价从870美元上调至885美元 * Ulta Beauty Inc   ：奥本海默将目标价从500美元下调至475美元 * Vertex Pharmaceuticals Inc   ：Piper Sandler将目标价从450美元上调至456美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IR","VERX","CTO","ATI","ACT","GOOD","BK4204","LINC","LU1064131342.USD","HIMS","PACS","BOWL","PLTR","ACA","BK4550","HWM","GOSS","IART","PNW","LMND","CAH","CRNX","GLYC","AIG","CIVI","BK4117","LYRA","FIS","ENTA","BK4567","NOW","MCHP","BCRX","BECN","FRPT","ARW","COTY","BV","LITE","BK4097","ACHC","EVER","DSGN","MTZ","VRTX","APA","KRC","LU0889566641.SGD","CTRA"],"gpt_icon":0},{"id":"2431147353","title":"Crinetics Pharmaceuticals Inc    预计每股亏损 81 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431147353","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431147353?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:06","pubTimestamp":1714475170,"startTime":"0","endTime":"0","summary":"   * Crinetics Pharmaceuticals Inc    预计将在5月2日公布截至2024年3月31日的季度业绩(估计)，季度收入将出现下降。* LSEG 分析师对 Crinetics Pharmaceuticals Inc 的平均预期是每股亏损 81 美分。* 华尔街对 Crinetics Pharmaceuticals Inc 的 12 个月目标价中位数为 56.00 美元，高于其上次收盘价 44.00 美元。4月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"gpt_icon":0},{"id":"2431111894","title":"Crinetics Pharmaceuticals, Inc.盘中异动 临近午盘大幅拉升5.02%报44.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431111894","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431111894?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:59","pubTimestamp":1714406374,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时59分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.02%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429235934861ea22f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429235934861ea22f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX","BK4139","ANVS"],"gpt_icon":0},{"id":"2426469293","title":"Crinetics Pharmaceuticals, Inc.盘中异动 大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426469293","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426469293?lang=zh_cn&edition=full","pubTime":"2024-04-12 01:15","pubTimestamp":1712855709,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日01时15分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.05%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Candel Therapeutics, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为762.08%、566.61%、509.10%，振幅较大的相关个股有Rallybio Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为50.92%、46.31%、42.60%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412011510791ff5c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412011510791ff5c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX","BK4139","RLYB","BK4539"],"gpt_icon":0},{"id":"2421720587","title":"Crinetics Pharmaceuticals, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421720587","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421720587?lang=zh_cn&edition=full","pubTime":"2024-03-21 00:17","pubTimestamp":1710951421,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日00时17分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.00%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210017027a4dfd92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210017027a4dfd92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRNX"],"gpt_icon":0},{"id":"2420798966","title":"美国研究综述-迪克体育用品、Nvidia、PVH","url":"https://stock-news.laohu8.com/highlight/detail?id=2420798966","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420798966?lang=zh_cn&edition=full","pubTime":"2024-03-20 15:14","pubTimestamp":1710918896,"startTime":"0","endTime":"0","summary":"    路透社3月20日 - 华尔街证券分析师周三调整了对迪克体育用品公司、英伟达和 PVH 等几家美国上市公司的评级和目标价。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNM","CAL","IE00BMPRXN33.USD","CSCO","BK4503","HQY","BK4213","RLMD","RIOT","SG9999002232.USD","SAIC","HLT","BK4212","BK4543","RAIL","HPP","BK4588","LU0053671581.USD","LU0170899867.USD","PLNT","BK4023","SNDX","PTCT","LU0444971666.USD","CRNX","SG9999002224.SGD","TRML","BK4216","SMPL","BRO","BK4527","BBIO","TNYA","GOCO","BK4139","IE00BWXC8680.SGD","RCM","DCPH","DKS","MTDR","ASO","NVDA","LU0238689110.USD","BK4505","PVH","LU0072462426.USD","LU0889565916.HKD","LU0731783394.SGD","BK4525","LU1430594728.SGD"],"gpt_icon":0},{"id":"2420276572","title":"Crinetics Pharmaceuticals, Inc.盘中异动 股价大涨10.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420276572","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420276572?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:31","pubTimestamp":1710855097,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日21时31分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价急速拉升10.37%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Fusion Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为434.43%、142.36%、117.45%，振幅较大的相关个股有Enveric Biosciences, Inc.、Salarius Pharmaceuticals, Inc.、Immuneering Corporation，振幅分别为17.27%、11.59%、11.27%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921313787986d81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921313787986d81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX","BK4139"],"gpt_icon":0},{"id":"2420242836","title":"BUZZ-Crinetics 因荷尔蒙紊乱后期治疗试验的成功而跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2420242836","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420242836?lang=zh_cn&edition=full","pubTime":"2024-03-19 19:07","pubTimestamp":1710846420,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月19日 - ** Crinetics Pharmaceuticals   股价盘前上涨 ~12% 至 42.49 美元** 该公司称 (link) 其口服药物 paltusotine 在一项晚期研究中达到了主要目标，该研究评估了它对肢端肥大症的治疗作用** 肢端肥大症是一种因体内生长激素分泌过多而导致的疾病。** CRNX称，56%的患者服用该药后能够维持生长因子水平，而服用安慰剂的患者仅为5%。** 截至上次收盘，该公司股价在过去 12 个月中上涨了一倍多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","CRNX"],"gpt_icon":0},{"id":"2420245598","title":"Crinetics Pharma 的荷尔蒙紊乱药物在后期研究中达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2420245598","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420245598?lang=zh_cn&edition=full","pubTime":"2024-03-19 18:08","pubTimestamp":1710842891,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社3月19日 - Crinetics Pharmaceuticals   周二称，其治疗荷尔蒙紊乱的实验性药物在一项后期研究中达到了主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crinetics.com","stockEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0223},{"period":"3month","weight":-0.0432},{"period":"6month","weight":0.2589},{"period":"1year","weight":1.5149},{"period":"ytd","weight":0.2589}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0344},{"period":"3month","weight":0.0404},{"period":"6month","weight":0.145},{"period":"1year","weight":0.2422},{"period":"ytd","weight":0.145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Crinetics Pharmaceuticals, Inc.于2008年11月18日根据特拉华州法律注册成立。该公司是一家临床阶段制药公司，致力于发现，开发和商业化用于治疗罕见内分泌疾病和内分泌相关肿瘤的新药。 内分泌途径的功能是保持体内平衡，并且通常使用通过G蛋白偶联受体或GPCRs起作用的肽激素来调节生理学的许多方面，包括生长，能量，代谢，胃肠功能和应激反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.081466},{"month":2,"riseRate":0.666667,"avgChangeRate":0.019442},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.046094},{"month":4,"riseRate":0.666667,"avgChangeRate":0.081043},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.006472},{"month":6,"riseRate":0.666667,"avgChangeRate":0.007507},{"month":7,"riseRate":0.4,"avgChangeRate":-0.071661},{"month":8,"riseRate":0.5,"avgChangeRate":0.060143},{"month":9,"riseRate":0.333333,"avgChangeRate":0.088598},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.013275},{"month":11,"riseRate":0.833333,"avgChangeRate":0.128238},{"month":12,"riseRate":0.833333,"avgChangeRate":0.063263}],"exchange":"NASDAQ","name":"Crinetics Pharmaceuticals Inc.","nameEN":"Crinetics Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Crinetics Pharmaceuticals Inc.,CRNX,Crinetics Pharmaceuticals Inc.股票,Crinetics Pharmaceuticals Inc.股票老虎,Crinetics Pharmaceuticals Inc.股票老虎国际,Crinetics Pharmaceuticals Inc.行情,Crinetics Pharmaceuticals Inc.股票行情,Crinetics Pharmaceuticals Inc.股价,Crinetics Pharmaceuticals Inc.股市,Crinetics Pharmaceuticals Inc.股票价格,Crinetics Pharmaceuticals Inc.股票交易,Crinetics Pharmaceuticals Inc.股票购买,Crinetics Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}